P072 LDN-071, a novel first-in-class amino acid-based PAI-1 inhibitor, significantly reduces the severity of experimental colitis in miceBoldizsár Jójárt, József Maléth, Bence Pál Barta et al.|Journal of Crohn s and Colitis|2024Cited by 0
DOP114 LDN-071, the novel amino acid-based PAI-1 inhibitor, significantly reduces the severity of acute and chronic inflammation in colitis modelsBoldizsár Jójárt, József Maléth, Noémi Csákány-Papp et al.|Journal of Crohn s and Colitis|2025Cited by 0